Aytu BioPharma, Inc. (AYTU) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Conference Call February 12, 2025 4:30 PM ETCompany ParticipantsRobert Blum - Investor Relations, ...
Aytu BioPharma, Inc.: Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results
Net income of $0.8 millionAdjusted EBITDA1 of $1.3 millionPediatric Portfolio net revenue up 86% sequentiallyFirst quarterly sequential prescription increase for both ADHD and Pediatric portfolios sin ...
X has been used to represent love and kisses for centuries. But how did it start?
While the origins of the cross as a kiss are still debated, the answer likely lies in the letters of working-class lovers ...
Kinross reports 2024 fourth-quarter and full-year results
Delivered on all key guidance metricsAchieved record free cash flow of more than $1.3 billion and repaid $800 million of debtStrong three-year ...
Kinross Gold Corporation: Kinross reports 2024 fourth-quarter and full-year results
Delivered on all key guidance metricsAchieved record free cash flow of more than $1.3 billion and repaid $800 million of debtStrong three-year outlook of 2.0 million Au eq. oz. per year TORONTO, Feb.
Zoetis Inc. (ZTS) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ETCompany ParticipantsSteve Frank - IRKristin Peck - CEOWetteny Joseph ...